Consequently, this study aims to provide a comprehensive investigation into the expression of SHROOM4 in NSCLC and its correlation with clinical outcomes and molecular features, with particular emphasis on lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). Here, SHROOM4 is linked to squamous cell lung carcinoma.